301520 万邦医药
已收盘 12-05 15:00:00
资讯
新帖
简况
万邦医药:截至2025年11月28日股东人数为7,963户
证券之星 · 12-01
万邦医药:截至2025年11月28日股东人数为7,963户
万邦医药:截止2025年11月20日股东人数为7,989户
证券之星 · 11-21
万邦医药:截止2025年11月20日股东人数为7,989户
万邦医药:截止2025年10月31日股东人数为8,277户
证券之星 · 11-04
万邦医药:截止2025年10月31日股东人数为8,277户
万邦医药(301520)2025年三季报简析:净利润同比下降57.44%,三费占比上升明显
证券之星 · 10-24
万邦医药(301520)2025年三季报简析:净利润同比下降57.44%,三费占比上升明显
万邦医药:截止2025年10月20日股东人数为8,174户
证券之星 · 10-23
万邦医药:截止2025年10月20日股东人数为8,174户
万邦医药(301520.SZ)发布前三季度业绩,归母净利润3311.06万元,下降57.44%
智通财经 · 10-22
万邦医药(301520.SZ)发布前三季度业绩,归母净利润3311.06万元,下降57.44%
股市必读:万邦医药(301520)10月16日董秘有最新回复
证券之星 · 10-17
股市必读:万邦医药(301520)10月16日董秘有最新回复
股市必读:万邦医药(301520)股东户数0.81万户,较上期减少2.48%
证券之星 · 10-13
股市必读:万邦医药(301520)股东户数0.81万户,较上期减少2.48%
万邦医药:截止2025年9月30日股东人数为8,086户
证券之星 · 10-10
万邦医药:截止2025年9月30日股东人数为8,086户
万邦医药:截止2025年9月19日股东人数为8,292户
证券之星 · 09-22
万邦医药:截止2025年9月19日股东人数为8,292户
股市必读:万邦医药(301520)股东户数0.84万户,较上期增加0.59%
证券之星 · 09-15
股市必读:万邦医药(301520)股东户数0.84万户,较上期增加0.59%
万邦医药:截止9月10日股东人数为8,360户
证券之星 · 09-12
万邦医药:截止9月10日股东人数为8,360户
万邦医药:截止2025年8月29日股东人数为8,311户
证券之星 · 09-03
万邦医药:截止2025年8月29日股东人数为8,311户
股市必读:万邦医药(301520)8月28日董秘有最新回复
证券之星 · 08-29
股市必读:万邦医药(301520)8月28日董秘有最新回复
万邦医药:持续聚焦主业发展提升经营管理水平
证券之星 · 08-26
万邦医药:持续聚焦主业发展提升经营管理水平
图解万邦医药中报:第二季度单季净利润同比下降40.97%
证券之星 · 08-26
图解万邦医药中报:第二季度单季净利润同比下降40.97%
万邦医药股价微跌0.04% 股东户数连续两期下降
金融界 · 08-22
万邦医药股价微跌0.04% 股东户数连续两期下降
万邦医药:截至2025年8月20日股东人数为8,699户
证券之星 · 08-22
万邦医药:截至2025年8月20日股东人数为8,699户
万邦医药:截止8月8日股东人数为9,277户
证券之星 · 08-21
万邦医药:截止8月8日股东人数为9,277户
万邦医药:坚持通过稳健经营和技术创新提升核心竞争力
金融界 · 08-18
万邦医药:坚持通过稳健经营和技术创新提升核心竞争力
加载更多
公司概况
公司名称:
安徽万邦医药科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2023-09-25
主营业务:
安徽万邦医药科技股份有限公司的主营业务是药学研究和临床研究服务的综合型CRO,通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理(SMO)、生物样本分析(BA)、数据管理与统计分析(DM/ST)、处方工艺研究、质量研究、稳定性研究。
发行价格:
67.88
{"stockData":{"symbol":"301520","market":"SZ","secType":"STK","nameCN":"万邦医药","latestPrice":41.19,"timestamp":1764918219000,"preClose":40.61,"halted":0,"volume":469300,"delay":0,"changeRate":0.0143,"floatShares":22423000,"shares":66666700,"eps":0.6127,"marketStatus":"已收盘","change":0.58,"latestTime":"12-05 15:00:00","open":40.68,"high":41.35,"low":40.36,"amount":19130300,"amplitude":0.0244,"askPrice":41.26,"askSize":2,"bidPrice":41.19,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.6127,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":40.61,"symbolType":"stock","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":44.67,"lowLimit":36.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":66666667,"isCdr":false,"pbRate":1.79,"roa":"--","peRate":67.227028,"roe":"2.21%","epsLYR":1.28,"committee":-0.073826,"marketValue":2746000000,"turnoverRate":0.0209,"status":0,"floatMarketCap":924000000},"requestUrl":"/m/hq/s/301520","defaultTab":"news","newsList":[{"id":"2588747416","title":"万邦医药:截至2025年11月28日股东人数为7,963户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747416?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576731,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年十一月 28日公司的股东总数是多少?谢谢万邦医药回复:尊敬的投资者您好!截止2025年11月28日,公司的股东人数为7,963户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2585113407","title":"万邦医药:截止2025年11月20日股东人数为7,989户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585113407?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:45","pubTimestamp":1763714737,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年十一月 20日公司的股东总数是多少?谢谢万邦医药回复:尊敬的投资者您好!截止2025年11月20日,公司的股东人数为7,989户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100022074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2580992272","title":"万邦医药:截止2025年10月31日股东人数为8,277户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580992272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580992272?lang=zh_cn&edition=full","pubTime":"2025-11-04 11:33","pubTimestamp":1762227207,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止10月31日股东户数是多少?谢谢万邦医药回复:尊敬的投资者您好!截止2025年10月31日,公司的股东人数为8,277户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400014526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2577537919","title":"万邦医药(301520)2025年三季报简析:净利润同比下降57.44%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2577537919","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577537919?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:07","pubTimestamp":1761257255,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期万邦医药发布2025年三季报。截至本报告期末,公司营业总收入2.09亿元,同比下降28.6%,归母净利润3311.06万元,同比下降57.44%。按单季度数据看,第三季度营业总收入6258.77万元,同比下降41.0%,第三季度归母净利润629.92万元,同比下降72.33%。本报告期万邦医药三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达53.08%。去年的净利率为22.56%,算上全部成本后,公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520"],"gpt_icon":0},{"id":"2577341367","title":"万邦医药:截止2025年10月20日股东人数为8,174户","url":"https://stock-news.laohu8.com/highlight/detail?id=2577341367","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577341367?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:55","pubTimestamp":1761180913,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年十月 20日公司的股东总数是多少?谢谢万邦医药回复:尊敬的投资者您好!截止2025年10月20日,公司的股东人数为8,174户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300006402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2577553369","title":"万邦医药(301520.SZ)发布前三季度业绩,归母净利润3311.06万元,下降57.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577553369","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577553369?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:44","pubTimestamp":1761133478,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万邦医药(301520.SZ)发布2025年三季度报告,该公司前三季度营业收入为2.09亿元,同比减少28.60%。归属于上市公司股东的净利润为3311.06万元,同比减少57.44%。归属于上市公司股东的扣除非经常性损益的净利润为844.92万元,同比减少84.89%。基本每股收益为0.5元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"万邦医药(301520.SZ)发布前三季度业绩,归母净利润3311.06万元,下降57.44%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301520"],"gpt_icon":0},{"id":"2576738847","title":"股市必读:万邦医药(301520)10月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576738847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576738847?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:10","pubTimestamp":1760645419,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘,万邦医药报收于41.49元,上涨0.12%,换手率3.06%,成交量6870.0手,成交额2846.57万元。董秘最新回复投资者: 董秘您好,请问公司有研究抗癌药物吗?公司是一家CRO企业,主营业务是为医药企业及研发机构提供专业化医药研发外包服务,承接过的项目包括为客户提供肿瘤患者用药的临床试验研究技术服务,不涉及自主研发抗癌药物。交易信息汇总资金流向10月16日主力资金净流入80.56万元;游资资金净流入258.58万元;散户资金净流出339.15万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700004157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2575410071","title":"股市必读:万邦医药(301520)股东户数0.81万户,较上期减少2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575410071","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575410071?lang=zh_cn&edition=full","pubTime":"2025-10-13 05:15","pubTimestamp":1760303720,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,万邦医药报收于41.47元,下跌0.07%,换手率1.63%,成交量3666.0手,成交额1521.89万元。交易信息汇总资金流向10月10日主力资金净流出151.46万元;游资资金净流入68.61万元;散户资金净流入82.84万元。股本股东变化股东户数变动截至2025年9月30日,万邦医药股东户数为8086.0户,较9月19日减少206.0户,减幅2.48%;户均持股数量上升至8245.0股,户均持股市值为34.41万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2574482291","title":"万邦医药:截止2025年9月30日股东人数为8,086户","url":"https://stock-news.laohu8.com/highlight/detail?id=2574482291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574482291?lang=zh_cn&edition=full","pubTime":"2025-10-10 11:33","pubTimestamp":1760067222,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问截止至2025年9月30日收盘公司股东人数为多少,谢谢!万邦医药回复:尊敬的投资者您好,截止2025年9月30日,公司的股东人数为8,086户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000014166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2569042482","title":"万邦医药:截止2025年9月19日股东人数为8,292户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569042482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569042482?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:09","pubTimestamp":1758528564,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司9月20日的股东人数是多少?谢谢万邦医药回复:尊敬的投资者您好,截止2025年9月19日,公司的股东人数为8,292户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200019498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2567615722","title":"股市必读:万邦医药(301520)股东户数0.84万户,较上期增加0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567615722","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567615722?lang=zh_cn&edition=full","pubTime":"2025-09-15 04:07","pubTimestamp":1757880433,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,万邦医药报收于44.01元,上涨0.69%,换手率3.65%,成交量8188.0手,成交额3569.68万元。当日关注点来自“交易信息汇总”:9月12日主力资金净流入421.79万元,显示主力对万邦医药的积极介入。股本股东变化股东户数变动近日万邦医药披露,截至2025年9月10日公司股东户数为8360.0户,较8月29日增加49.0户,增幅为0.59%。户均持股数量由上期的8022.0股减少至7974.0股,户均持股市值为34.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500001266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2566454819","title":"万邦医药:截止9月10日股东人数为8,360户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566454819","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566454819?lang=zh_cn&edition=full","pubTime":"2025-09-12 09:09","pubTimestamp":1757639357,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止9月10日的股东人数是多少?谢谢万邦医药回复:尊敬的投资者您好,截止2025年9月10日,公司的股东人数为8,360户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200006175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2564356897","title":"万邦医药:截止2025年8月29日股东人数为8,311户","url":"https://stock-news.laohu8.com/highlight/detail?id=2564356897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564356897?lang=zh_cn&edition=full","pubTime":"2025-09-03 11:33","pubTimestamp":1756870422,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的领导,请问8月30日股东人数是多少?谢谢万邦医药回复:尊敬的投资者您好,截止2025年8月29日,公司的股东人数为8,311户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300014594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2563185064","title":"股市必读:万邦医药(301520)8月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2563185064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563185064?lang=zh_cn&edition=full","pubTime":"2025-08-29 05:43","pubTimestamp":1756417395,"startTime":"0","endTime":"0","summary":"截至2025年8月28日收盘,万邦医药报收于43.23元,下跌1.53%,换手率8.16%,成交量1.83万手,成交额7874.73万元。董秘最新回复投资者: 公司股价持续低迷,希望公司回购,大股东增持,维护股东利益和公司形象,谢谢。公司高度重视股东利益,始终致力于通过多种方式维护公司价值及投资者信心。当日关注点来自交易信息汇总:8月28日主力资金净流出889.06万元,显示主力资金呈离场态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900004655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2562778988","title":"万邦医药:持续聚焦主业发展提升经营管理水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562778988?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:57","pubTimestamp":1756198645,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药08月26日在投资者关系平台上答复投资者关心的问题。是不是应该想点办法让股价回到发行价之上呢?未来,公司将持续聚焦主业发展、提升经营管理水平、提高信息披露质量,以回报广大投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600033170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2562622419","title":"图解万邦医药中报:第二季度单季净利润同比下降40.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562622419","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562622419?lang=zh_cn&edition=full","pubTime":"2025-08-26 02:40","pubTimestamp":1756147214,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药2025年中报显示,公司主营收入1.47亿元,同比下降21.57%;归母净利润2681.14万元,同比下降51.28%;扣非净利润1232.7万元,同比下降70.17%;其中2025年第二季度,公司单季度主营收入7578.61万元,同比下降21.9%;单季度归母净利润1496.21万元,同比下降40.97%;单季度扣非净利润696.82万元,同比下降62.5%;负债率5.48%,投资收益263.84万元,财务费用-75.32万元,毛利率34.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600003925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520"],"gpt_icon":0},{"id":"2561213479","title":"万邦医药股价微跌0.04% 股东户数连续两期下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2561213479","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561213479?lang=zh_cn&edition=full","pubTime":"2025-08-22 19:55","pubTimestamp":1755863727,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘,万邦医药股价报45.81元,较前一交易日下跌0.04%,成交额0.70亿元。万邦医药属于医疗服务板块,主营业务为创新药临床试验外包服务(CRO)。公司2024年全年营业收入全部来自CRO行业。消息面上,万邦医药8月22日披露,截至8月20日,公司股东户数为8699户,较上期减少6.23%,连续两期下降。此外,公司于8月21日召开董事会会议,审议了聘任高级管理人员等议案。资金流向方面,8月22日主力资金净流出405.56万元,近五日累计净流出1251.68万元。风险提示:股市有风险,投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/22195552629759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2561339424","title":"万邦医药:截至2025年8月20日股东人数为8,699户","url":"https://stock-news.laohu8.com/highlight/detail?id=2561339424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561339424?lang=zh_cn&edition=full","pubTime":"2025-08-22 16:18","pubTimestamp":1755850697,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)08月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问8月20日股东人数是多少?谢谢万邦医药回复:尊敬的投资者您好,截至2025年8月20日,公司的股东人数为8,699户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200028868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2561376764","title":"万邦医药:截止8月8日股东人数为9,277户","url":"https://stock-news.laohu8.com/highlight/detail?id=2561376764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561376764?lang=zh_cn&edition=full","pubTime":"2025-08-21 11:36","pubTimestamp":1755747387,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)08月20日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止8月8日股东人数是多少?谢谢万邦医药回复:尊敬的投资者您好,截止2025年8月8日,公司的股东人数为9,277户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100014494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2560705449","title":"万邦医药:坚持通过稳健经营和技术创新提升核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2560705449","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560705449?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:40","pubTimestamp":1755506447,"startTime":"0","endTime":"0","summary":"金融界8月18日消息,有投资者在互动平台向万邦医药提问:2025年中报即将公布,中期分红回报投资者吗?公司回答表示:尊敬的投资者您好,公司始终高度重视股东回报,坚持通过稳健经营、精细化管理和持续的技术创新,不断提升核心竞争力与盈利能力,致力于为股东创造长期稳定的价值。如有相关计划,公司将严格按照规定及时履行信息披露义务。感谢您的关注!","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/18164052505203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","301520"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765134448838,"stockEarnings":[{"period":"1week","weight":-0.0181},{"period":"1month","weight":-0.0376},{"period":"3month","weight":-0.0585},{"period":"6month","weight":-0.0024},{"period":"1year","weight":-0.0153},{"period":"ytd","weight":0.0798}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽万邦医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"7963人(较上一季度减少0.33%)","perCapita":"2815股","listingDate":"2023-09-25","address":"安徽省合肥市蜀山区高新区火龙地路299号","registeredCapital":"6666万元","survey":" 安徽万邦医药科技股份有限公司的主营业务是药学研究和临床研究服务的综合型CRO,通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理(SMO)、生物样本分析(BA)、数据管理与统计分析(DM/ST)、处方工艺研究、质量研究、稳定性研究。","listedPrice":67.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦医药,301520,万邦医药股票,万邦医药股票老虎,万邦医药股票老虎国际,万邦医药行情,万邦医药股票行情,万邦医药股价,万邦医药股市,万邦医药股票价格,万邦医药股票交易,万邦医药股票购买,万邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}